Search Results - "Golafshar, Michael"

Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study by Uson, Pedro L.S., Riegert-Johnson, Douglas, Boardman, Lisa, Kisiel, John, Mountjoy, Luke, Patel, Neej, Lizaola-Mayo, Blanca, Borad, Mitesh J., Ahn, Daniel, Sonbol, Mohamad B., Jones, Jeremy, Leighton, Jonathan A., Gurudu, Suryakanth, Singh, Harminder, Klint, Margaret, Kunze, Katie L., Golafshar, Michael A., Esplin, Ed D., Nussbaum, Robert L., Stewart, A. Keith, Bekaii-Saab, Tanio S., Jewel Samadder, Niloy

“…Hereditary factors play a role in the development of colorectal cancer (CRC). Identification of germline predisposition can have implications on treatment and…”
Get full text

Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study by Choudry, Mouneeb M., Durant, Adri M., Edmonds, Victoria S., Warren, Christopher J., Kunze, Katie L., Golafshar, Michael A., Nielsen, Sarah M., Esplin, Edward D., Andrews, Jack R., Samadder, N. Jewel, Tyson, Mark D.

“…This study aimed to investigate the prevalence of pathogenic germline variants (PGVs) in hereditary cancer genes utilizing a universal testing approach and to…”
Get full text

Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects by DeWees, Todd A., Mazza, Gina L., Golafshar, Michael A., Dueck, Amylou C.

“…Utilization of parametric or nonparametric methods for testing Likert scale data is often debated. This 2-part simulation study aims to investigate the…”
Get full text

Germline Genetic Testing in Unselected Squamous and Non-Squamous Head and Neck Cancers by Brake, Daniela A, Idler, Beau M, Kunze, Katie L, Golafshar, Michael A, Heald, Brandie, Young, Sarah, Klint, Margaret, Barrus, Kathleen, Esplin, Edward D, Nussbaum, Robert L, Samadder, N Jewel, Hinni, Michael L, Chang, Brent A

“…This study describes the prevalence of pathogenic germline variants (PGVs) in head and neck cancer patients, the incremental yield compared to a…”
Get full text

Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery by Laughlin, Brady S., Corbin, Kimberly S., Toesca, Diego Augusto Santos, Thorpe, Cameron S., Golafshar, Michael A., Pockaj, Barbara, Cronin, Patricia, McGee, Lisa A., Halyard, Michele Y., Mutter, Robert W., Keole, Sameer R., Park, Sean S., Shumway, Dean A., Vern-Gross, Tamara Z., Vallow, Laura, Wong, William W., DeWees, Todd A., Vargas, Carlos E.

“…Our aim was to report physician- and patient-reported outcomes of patients with localized breast cancer treated with moderate versus ultrahypofractionated…”
Get full text

Long‐term experience with intraoperative electron radiation therapy boost in extremity sarcoma by Laughlin, Brady S., Golafshar, Michael A., Lin, Keldon, Goulding, Krista, Roesler, Kimberly, Vern‐Gross, Tamara, Seetharam, Mahesh, Zaniletti, Isabella, Ashman, Jonathan B.

“…Background In patients with extremity soft tissue sarcoma (eSTS), we describe outcomes of preoperative external beam radiation therapy (EBRT), limb‐sparing…”
Get full text

Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease Mapping by Zahrieh, David, Golafshar, Michael A, Patel, Samir H, DeWees, Todd A

“…The incidence of breast cancer among non-Hispanic American Indian and Alaska Native (AI/AN) women varies across the United States. We applied county-level…”
Get full text

Machine learning helps predict long-term mortality and graft failure in patients undergoing heart transplant by Agasthi, Pradyumna, Buras, Matthew R., Smith, Sean D., Golafshar, Michael A., Mookadam, Farouk, Anand, Senthil, Rosenthal, Julie L., Hardaway, Brian W., DeValeria, Patrick, Arsanjani, Reza

“…Objective We aimed to develop a risk prediction model using a machine learning to predict survival and graft failure (GF) 5 years after orthotopic heart…”
Get full text

Patient Versus Caregiver: Correlation and Differences in Pediatric Quality of Life Using a Prospective Registry in a Large-Volume, Multisite Practice by Buras, Matthew R., Breen, William G., Laack, Nadia N., Gross, Tamara Vern, Zaniletti, Isabella, Leavitt, Todd, Golafshar, Michael A., Voss, Molly M., Mahajan, Anita, Keole, Sameer R., Ahmed, Safia K., Ulbrich, Annissa, Daniels, Thomas B., DeWees, Todd A.

“…Patient-reported outcomes provide quality of life (QOL) data during and after radiation. When pediatric patients are unable to complete patient-reported…”
Get full text

Utilizing open-source platforms to build and deploy interactive patient-reported quality of life tracking tools for monitoring protocol adherence by Golafshar, Michael A., Petersen, Molly, Vargas, Carlos E., Samadder, N. Jewel, Kunze, Katie L., McCormick, Nicole, Watkin, Shelby A., Maleyeva, Diana, Cheng, Tiffany W., Vargas, Manuel, DeWees, Todd A.

“…Purpose Tracking patient-reported outcomes (PROs) and quality-of-life response rates is essential for clinical trials. Historically, rates are monitored…”
Get full text

Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial by Mutter, Robert W., Golafshar, Michael A., Buras, Matthew R., Comstock, Bryce P., Jacobson, Maddi, DeWees, Todd, Remmes, Nicholas B., Francis, Leah N., Boughey, Judy C., Ruddy, Kathryn J., McGee, Lisa A., Afzal, Arslan, Vallow, Laura A., Furutani, Keith M., Deufel, Christopher L., Shumway, Dean A., Kim, Haeyoung, Liu, Minetta C., Degnim, Amy C., Jakub, James W., Vern-Gross, Tamara Z., Wong, William W., Patel, Samir H., Vargas, Carlos E., Stish, Bradley J., Waddle, Mark R., Pafundi, Deanna H., Halyard, Michele Y., Corbin, Kimberly S., Hieken, Tina J., Park, Sean S.

“…The optimal approach for partial breast irradiation (PBI) is unknown. We investigated a novel de-intensified 3-fraction PBI regimen for photons, protons, and…”
Get full text

Analytical Methods for Observational Data to Generate Hypotheses and Inform Clinical Decisions by DeWees, Todd A., Vargas, Carlos E., Golafshar, Michael A., Harmsen, William Scott, Dueck, Amylou C.

“…Randomized controlled trials have been considered the gold standard in informing clinical decision-making while observational studies have generally been…”
Get full text

Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study by Uson Junior, Pedro Ls, Kunze, Katie L, Golafshar, Michael A, Riegert-Johnson, Douglas, Boardman, Lisa, Borad, Mitesh J, Ahn, Daniel, Sonbol, Mohamad B, Faigel, Douglas O, Fukami, Norio, Pannala, Rahul, Barrus, Kathleen, Mountjoy, Luke, Esplin, Edward D, Nussbaum, Robert L, Stewart, A Keith, Bekaii-Saab, Tanios, Samadder, N Jewel

“…Data from germline testing in unselected patients with hepatobiliary cancers are limited. Identification of germline predisposition can have important…”
Get full text

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors by Yu, Nathan Y., MD, Gamez, Mauricio E., MD, Hartsell, William F., MD, Tsai, Henry K., MD, Laramore, George E., MD, PhD, Larson, Gary L., MD, Simone, Charles B., MD, Rossi, Carl, MD, Katz, Sanford R., MD, Buras, Matthew R., MS, Golafshar, Michael A., MS, Vargas, Carlos E., MD, Patel, Samir H., MD

“…AbstractPurposeTo report the outcomes of sinonasal tumors treated with proton beam therapy (PBT) on the Proton Collaborative Group registry study. Methods and…”
Get full text

Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience by Laughlin, Brady S., Bhangoo, Ronik S., Thorpe, Cameron S., Golafshar, Michael A., DeWees, Todd A., Anderson, Justin D., Vern-Gross, Tamara Z., McGee, Lisa A., Wong, William W., Halyard, Michele Y., Keole, Sameer R., Vargas, Carlos E.

“…BackgroundWe present Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for patients undergoing adjuvant…”
Get full text

A Comparison of Perceived Lifetime Breast Cancer Risk to Calculated Lifetime Risk Using the Gail Risk Assessment Tool by Mehta, Jaya, MacLaughlin, Kathy L, Millstine, Denise M, Faubion, Stephanie S, Wallace, Mark R, Shah, Amit A, Fields, Heather E, Ruddy, Barbara E, Bryan, Michael J, Patel, Bhavika K, Buras, Matthew R, Golafshar, Michael A, Kling, Juliana M

“…Understanding the accuracy of a woman's perceived breast cancer risk can enhance shared decision-making about breast cancer screening through provider and…”
Get more information

Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience by Bhangoo, Ronik S., DeWees, Todd A., Yu, Nathan Y., Ding, Julia X., Liu, Chenbin, Golafshar, Michael A., Rule, William G., Vora, Sujay A., Ross, Helen J., Ahn, Daniel H., Beamer, Staci E., Jaroszewski, Dawn E., Hallemeier, Christopher L., Liu, Wei, Ashman, Jonathan B., Sio, Terence T.

“…Intensity modulated proton beam radiation therapy (IMPT) has a clinically significant dosimetric advantage over intensity modulated photon radiation therapy…”
Get full text

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience by Bhangoo, Ronik S., Mullikin, Trey C., Ashman, Jonathan B., Cheng, Tiffany W., Golafshar, Michael A., DeWees, Todd A., Johnson, Jedediah E., Shiraishi, Satomi, Liu, Wei, Hu, Yanle, Merrell, Kenneth W., Haddock, Michael G., Krishnan, Sunil, Rule, William G., Sio, Terence T., Hallemeier, Christopher L.

“…Our purpose was to assess the safety and efficacy of intensity modulated proton therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). A…”
Get full text

Breast Cancer Screening: Women's Attitudes and Beliefs in Light of Updated United States Preventive Services Task Force and American Cancer Society Guidelines by Mehta, Jaya M, MacLaughlin, Kathy L, Millstine, Denise M, Faubion, Stephanie S, Wallace, Mark R, Shah, Amit A, Fields, Heather E, Ruddy, Barbara E, Bryan, Michael J, Patel, Bhavika, Temkit, M' Hamed, Buras, Matthew R, Golafshar, Michael A, Kling, Juliana M

“…In recently updated breast cancer screening guidelines, the American Cancer Society (ACS) and United States Preventive Services Task Force (USPSTF) recommended…”
Get more information

Risk of Recurrence and 10-Year Outcomes in Surgically Treated Nonmelanoma Skin Cancer in Cardiac and Liver Transplant Recipients by Yu, Nathan Y., DeWees, Todd A., Alam, Mustafa, Ochoa, Shari A., Mangold, Aaron R., Steidley, David E., Vargas, Hugo E., Golafshar, Michael A., Schild, Steven E., Halyard, Michele Y., Patel, Samir H.

“…To report long-term outcomes of nonmelanoma skin cancer (NMSC) in immunosuppressed cardiac and liver transplant recipients (CLTR). The authors reviewed CLTR at…”
Get full text